<code id='22F5CE2D51'></code><style id='22F5CE2D51'></style>
    • <acronym id='22F5CE2D51'></acronym>
      <center id='22F5CE2D51'><center id='22F5CE2D51'><tfoot id='22F5CE2D51'></tfoot></center><abbr id='22F5CE2D51'><dir id='22F5CE2D51'><tfoot id='22F5CE2D51'></tfoot><noframes id='22F5CE2D51'>

    • <optgroup id='22F5CE2D51'><strike id='22F5CE2D51'><sup id='22F5CE2D51'></sup></strike><code id='22F5CE2D51'></code></optgroup>
        1. <b id='22F5CE2D51'><label id='22F5CE2D51'><select id='22F5CE2D51'><dt id='22F5CE2D51'><span id='22F5CE2D51'></span></dt></select></label></b><u id='22F5CE2D51'></u>
          <i id='22F5CE2D51'><strike id='22F5CE2D51'><tt id='22F5CE2D51'><pre id='22F5CE2D51'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:9
          Adobe

          LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

          The deal includes up to another $400 million in payments if certain milestones are met.

          advertisement

          Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Roche's accidental data boosts hopes for anti
          Roche's accidental data boosts hopes for anti

          SEBASTIENBOZON/AFPviaGettyImagesThemultibillion-dollarhuntforwhatmanydrugmakershopewillbethenextbigi

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Why the world’s most expensive drug might be worth the price

          AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b